behaelterbau

Tanks & apparatus building

Custom tanks and systems designed and manufactured for you

We develop, manufacture and inspect vessels and process systems for the manufacture, preparation and storage of your products, particularly in the pharmaceutical, food, cosmetics and chemical industries.

Industry applications in detail

Our process tanks set standards when it comes to the safety, purity and reproducibility of pharmaceutical formulations.

Our sterile tanks are easy to clean, have a compact design and feature innovative engineering. As an established supplier for the pharmaceuticals industry, we have numerous references when it comes to tanks for stirring and mixing sterile products.

Our tanks are used to produce, fill and store:

  • serums
  • liquids
  • tablets
  • coatings
  • pastes and balms

For sterile and non-sterile environments, in areas at risk of explosion (ATEX) or under atmospheric conditions, as pressurised tanks, as depressurised tanks or for use under a vacuum.

Our tanks are used by renowned, leading pharmaceutical companies, producers of generic medicines and subcontractors.

Product groups from the tanks & apparatus building segment

Bild84

Sterile equipment

Systems for the manufacture and process monitoring of vaccines under sterile conditions.
to the articles
Request article group
ansatzanlage1

Sterile tank

Mobile systems for the manufacture and process monitoring of vaccines under sterile conditions.
to the articles
Request article group
Bild85

Complex pipe/process systems

Stationary process tanks with stirrers and process measurement technology for various applications and stirring processes in vacuum, pressurised and unpressurised processes.
to the articles
Request article group
Bild14

Stirring tank

Mobile and stationary tanks to stir and mix fluids.
to the articles
Request article group
Bild58

Coating tanks

Mobile process tanks with the smallest possible stirring and residual stirring volume for coating and spraying liquids.
to the articles
Request article group
CIP -11

CIP tank

Stationary stirring and storage containers to prepare and store cleaning and CIP fluids.
to the articles
Request article group
ansatzanlage1

Process tanks

System for the manufacturing and process monitoring of of products under non-sterile conditions.
to the articles
Request article group
filtrat2

Filtration tank

Process and storage tank for filtrate and chromatography processes.
to the articles
Request article group
ansatzanlage1

Storage tank

Stationary and mobile storing tanks for solid, fluid and semi-solid products.
to the articles
Request article group
Sonstige-Behaelter-Pulvermischer

Other tanks

Reactors, vacuum tanks, swivel tanks, custom tanks.
to the articles
Request article group

Tank & apparatus building design options

  • Single-walled or multiple-walled tank (with heating/cooling & insulating jacket)
  • With stirring units & fittings
  • With measurement, control & regulation technology
  • Pressurised tank (pursuant to DGRL 2014/68/EU)
  • ATEX tank (pursuant to Directive 2014/34/EU)
  • Vacuum tank
  • Pressurised tank pursuant to GOST
  • Depressurised tank

Company

portfolio

links

Dear Sir or Madam,
Dear Mr Weinert,
27.04.2021


On April 30, 2021, we will open another site at Allergopharma GmbH & Co. KG in Reinbek to support COVID 19 vaccine production in the presence of Federal Minister Spahn and Minister President Günther. We would have been pleased to invite you to this opening.

Unfortunately, this was not possible due to the pandemic.
We would therefore like to take this opportunity to thank you for your extraordinary commitment to supplying equipment at short notice to support vaccine production. Allergopharma, as part of Dermapharm Holding SE, is now a further partner in the Europe-wide production network for the vaccine of BioNTech and Pfizer. This network now comprises more than a dozen important pharmaceutical manufacturers and suppliers. From now on, one of four production steps will take place in Reinbek: the vaccine formulation. This is where our mRNA active ingredient is combined with the lipids. A protective shell is created around the mRNA and the vaccine can reach its target in the body to induce the necessary immune response.


Your company has made a very important contribution to the global pandemic response with great know-how and under incredible time pressure. We would like to express our sincere thanks to you and your team! Without their commitment, the successful completion of the project would not have been possible.
We look forward to working with you in partnership in the future!

Dr. Hans-Georg Feldmeier – CEO Dermapharm SE
Dr. Sierk Poetting – CFO and COO BioNTech SE